Acute myeloid leukaemia after treatment with90Y-ibritumomab tiuxetan for follicular lymphoma

Authors :: Daniele Focosi
Mario Petrini
Sara Galimberti
Nadia Cecconi
Enrico Orciuolo
Giuseppe Boni
Source :: Hematological Oncology. 26:179-181
Publication Year :: 2008
Publisher :: Wiley, 2008.
Abstract: We report here a patient with relapsed follicular lymphoma who developed secondary acute myeloid leukaemia 15 months after radioimmunotherapy (RIT) with (90)Y-ibritumomab tiuxetan, the fifth described case to date. We review the literature for the potential causal relationship between RIT and secondary myelodysplastic syndromes/acute myeloid leukaemia.

Full Text Access

Tools